Z78-29956-17560 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Dose 1 — Pfizer-BioNTech
2021-01-18
Dose 2 — Pfizer-BioNTech
2021-01-19
Registered in v-safe
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-08
Survey response — day 21, dose 2
MedDRA: Cough, Headache, Paranasal sinus discomfort, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Fever, cough, headache, congestion, sinus pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-17
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-02-22
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-19
Call 1 — Left Voicemail
2021-11-29
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-12-10
Dose 3 — Pfizer-BioNTech
2022-01-18
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-24
Dose 4 — Pfizer-BioNTech
2022-10-04
Health check-in — day 7, dose 4
Feeling: Good · Site: Pain · None

Adult check-in
2022-10-08
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-15
Survey response — day 21, dose 4
MedDRA: Cough, Nasal congestion, Paranasal sinus discomfort, Upper respiratory tract infection — Feeling: Fair

Free text: Symptoms of upper respiratory infection: cough, sinus pressure, nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-10-22
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-12-24
Health check-in — 3 months, dose 4
Feeling: Fair

Adult check-in
2023-03-25
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Pfizer-BioNTech
2	2021-01-18	Pfizer-BioNTech
3	2021-12-10	Pfizer-BioNTech	No
4	2022-09-24	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-02-08	Successful 2021-11-29	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 3 — day 21, dose 2

2021-02-08

Symptoms: Fever, cough, headache, congestion, sinus pressure

Release 12 — day 21, dose 4

2022-10-15

Symptoms: Symptoms of upper respiratory infection: cough, sinus pressure, nasal congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Nasal congestion	·	·	✓
SD	Paranasal sinus discomfort	✓	✓	✓
SD	Pyrexia	✓	✓	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Upper respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release